• 1
    Lay CS, Tsai YT, Teg C, Shyu WS, Guo WS, Wu KL, Lo KJ. Endoscopic variceal prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997; 25: 13461350.
  • 2
    Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991; 324: 15321538.
  • 3
    Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800809.
  • 4
    Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. HEPATOLOGY 1998; 28: 868880.
  • 5
    The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988; 319: 983989.
  • 6
    Zoli M, Merkel C, Magalotti D, Marchesini G, Gatta A, Pisi E. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. HEPATOLOGY 1996; 24: 10471052.
  • 7
    Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002; 122L: 16201630.
  • 8
    De Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology, and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846852.
  • 9
    Angulo P, Lindor KD. Primary sclerosing cholangitis. HEPATOLOGY 1999; 30: 325332.
  • 10
    Angulo P, Larson DR, Therneau TM, LaRusso NF, Batts KP, Lindor KL. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 33103313.
    Direct Link:
  • 11
    Burak KW, Angulo PG, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis (PSC)? Am J Gastroenterol 2003; 98: 11551158.
    Direct Link:
  • 12
    Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 2000; 75: 688694.
  • 13
    Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, Madichetty H. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999; 94: 32853291.
    Direct Link:
  • 14
    Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, D'amico G. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? HEPATOLOGY 2001; 22: 333338.
  • 15
    Riggio O, Angeloni S, Nicolini G, Merli M, Merkel C. Endoscopic screening for esophageal varices in cirrhotic patients. HEPATOLOGY 2002; 35: 501502.
  • 16
    Spiegel B, Targownik L, Dulai GS. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective? HEPATOLOGY 2003; 37: 366377.
  • 17
    Ludwig J, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. In: RLPeters, JGCraig, eds. Contemporary issues in surgical pathology: liver pathology. New York: Churchill Livingstone, 1986: 193213.
  • 18
    MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149: 3944.
  • 19
    Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980; 10: 8487.
  • 20
    Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 2001; 161: 25642570.
  • 21
    Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 8185.